Vascepa is derived from fish oil, but it is not the same thing as the fish oil supplements you find on store shelves. Vascepa contains a single, highly purified omega-3 fatty acid called EPA, with each capsule delivering 960 mg of it. Over-the-counter fish oil supplements contain a mix of EPA and DHA along with other fats, at concentrations that vary widely from bottle to bottle. That distinction matters because Vascepa is an FDA-approved prescription medication with clinical evidence behind it, while fish oil supplements are not required to prove they work before being sold.
What Vascepa Actually Contains
The active ingredient in Vascepa is icosapent ethyl, a purified and concentrated form of EPA (eicosapentaenoic acid). EPA is one of two main omega-3 fatty acids found naturally in oily fish. Standard fish oil supplements contain both EPA and DHA (docosahexaenoic acid), typically in modest amounts alongside saturated fats and other compounds. Vascepa strips all of that away. What remains is exclusively EPA in ethyl ester form, standardized to a precise dose in every capsule.
The standard daily dose is four capsules, taken two at a time with meals, delivering a total of about 4 grams of EPA per day. To get that much EPA from a typical over-the-counter fish oil capsule, you would need to take a large handful of pills, and you’d be consuming a significant amount of DHA and other fats along with it.
How It Differs From Store-Bought Fish Oil
The differences go beyond just what’s inside the capsule. Prescription omega-3 products like Vascepa must meet the same rigorous FDA standards as any other drug: proven safety, demonstrated effectiveness, and tightly controlled manufacturing. Dietary fish oil supplements follow looser rules designed for food products. The quality and quantity of omega-3s in supplements can vary significantly from what the label claims.
There are more than 100 fish oil supplements on the market containing various combinations of EPA and DHA. None of them have been required to demonstrate that they reduce heart attacks, strokes, or other cardiovascular events. Vascepa has. That regulatory gap is one reason cardiologists distinguish sharply between prescription EPA and supplement-grade fish oil, even though both originate from the same source.
Another key difference: fish oil supplements containing DHA can raise LDL (“bad”) cholesterol in some people. Vascepa does not raise LDL cholesterol levels, which is one reason it was developed as an EPA-only product.
What Vascepa Is Prescribed For
Vascepa carries two FDA-approved uses. The first is lowering severely high triglycerides (500 mg/dL or above). The second, and more notable, is reducing the risk of heart attack, stroke, and other cardiovascular events in adults who are already on statin therapy but still have elevated triglycerides between 150 and 499 mg/dL along with existing heart disease or diabetes plus additional risk factors.
That second use is based on a large clinical trial called REDUCE-IT, which enrolled over 8,000 patients. Among those taking Vascepa, major cardiovascular events dropped by 25% compared to placebo. In the U.S. portion of the trial, the reduction was even more pronounced at 31%, with one cardiovascular event prevented for every 15 patients treated.
The 2026 joint guideline from the American College of Cardiology and the American Heart Association specifically identifies Vascepa as the only triglyceride-lowering medication that reduces cardiovascular event risk when added to statin therapy. No generic fish oil supplement carries that distinction.
How It Works in the Body
Vascepa lowers triglycerides through several mechanisms. It reduces the liver’s production and release of triglyceride-rich particles into the bloodstream while also increasing the body’s ability to clear those particles from circulation. It slows fat production in the liver and enhances the breakdown of fatty acids for energy.
The cardiovascular benefit likely extends beyond triglyceride lowering alone. High-dose EPA also reduces the number of LDL particles, lowers levels of a protein linked to plaque buildup, and decreases leftover cholesterol fragments that contribute to artery damage. Researchers believe these combined effects explain why Vascepa reduced heart events by more than triglyceride reduction alone would predict.
Risks and Side Effects
Vascepa is generally well tolerated, but it carries some notable risks. In clinical trials, people taking it had higher rates of hospitalization for new-onset atrial fibrillation (an irregular heart rhythm) compared to those on placebo, though the overall numbers were low. Serious bleeding events also occurred more frequently in the Vascepa group, and peripheral edema (swelling in the legs or ankles) was reported more often.
If you take blood thinners or have a history of irregular heart rhythms, these risks are worth discussing before starting treatment. The bleeding risk is consistent with what you’d expect from high-dose omega-3 fatty acids, which have a mild blood-thinning effect at therapeutic levels.
The Bottom Line on Vascepa and Fish Oil
Vascepa comes from fish oil, but calling it “fish oil” is like calling a pharmaceutical-grade antibiotic “mold” because penicillin originated from a fungus. The raw material is the same, but the final product is fundamentally different in purity, dose, consistency, and proven clinical benefit. Over-the-counter fish oil supplements have not been shown to prevent heart attacks or strokes, while Vascepa has, at a specific dose, in a specific population of patients with elevated cardiovascular risk. They are not interchangeable.